首页> 外文期刊>Science >MicroRNA-92a Controls Angiogenesis and Functional Recovery of Ischemic Tissues in Mice
【24h】

MicroRNA-92a Controls Angiogenesis and Functional Recovery of Ischemic Tissues in Mice

机译:MicroRNA-92a控制小鼠缺血组织的血管生成和功能恢复。

获取原文
获取原文并翻译 | 示例
       

摘要

MicroRNAs (miRs) are small noncoding RNAs that regulate gene expression by binding to target messenger RNAs (mRNAs), leading to translational repression or degradation. Here, we show that the miR-17~92 cluster is highly expressed in human endothelial cells and that miR-92a, a component of this cluster, controls the growth of new blood vessels (angiogenesis). Forced overexpression of miR-92a in endothelial cells blocked angiogenesis in vitro and in vivo. In mouse models of limb ischemia and myocardial infarction, systemic administration of an antagomir designed to inhibit miR-92a led to enhanced blood vessel growth and functional recovery of damaged tissue. MiR-92a appears to target mRNAs corresponding to several proangiogenic proteins, including the integrin subunit alpha5. Thus, miR-92a may serve as a valuable therapeutic target in the setting of ischemic disease.
机译:微小RNA(miR)是小的非编码RNA,通过与靶信使RNA(mRNA)结合来调节基因表达,从而导致翻译抑制或降解。在这里,我们证明了miR-17〜92簇在人内皮细胞中高表达,而miR-92a是该簇的组成部分,控制着新血管的生长(血管生成)。在体外和体内,miR-92a在内皮细胞中的过度表达会阻断血管生成。在肢体缺血和心肌梗塞的小鼠模型中,全身性给药旨在抑制miR-92a的antagomir全身给药可增强血管生长和受损组织的功能恢复。 MiR-92a似乎靶向与几种促血管生成蛋白(包括整联蛋白亚基alpha5)相对应的mRNA。因此,miR-92a可以作为缺血性疾病中有价值的治疗靶标。

著录项

  • 来源
    《Science》 |2009年第5935期|1710-1713|共4页
  • 作者单位

    Institute for Cardiovascular Regeneration, Centre of Molec- ular Medicine, Goethe-University Frankfurt, 60590 Frankfurt, Germany;

    Institute for Cardiovascular Regeneration, Centre of Molec- ular Medicine, Goethe-University Frankfurt, 60590 Frankfurt, Germany;

    Institute for Cardiovascular Regeneration, Centre of Molec- ular Medicine, Goethe-University Frankfurt, 60590 Frankfurt, Germany;

    Italian Foundation for Cancer Research Institute of Molecular Oncology Foundation, 02139 Milan, Italy;

    Institute for Cardiovascular Regeneration, Centre of Molec- ular Medicine, Goethe-University Frankfurt, 60590 Frankfurt, Germany;

    Institute for Cardiovascular Regeneration, Centre of Molec- ular Medicine, Goethe-University Frankfurt, 60590 Frankfurt, Germany;

    Institute for Cardiovascular Regeneration, Centre of Molec- ular Medicine, Goethe-University Frankfurt, 60590 Frankfurt, Germany;

    Institute for Cardiovascular Regeneration, Centre of Molec- ular Medicine, Goethe-University Frankfurt, 60590 Frankfurt, Germany Division of Cardiology, Department of Medicine III, Goethe-University Frankfurt, 60590 Frankfurt, Germany;

    Institute for Cardiovascular Regeneration, Centre of Molec- ular Medicine, Goethe-University Frankfurt, 60590 Frankfurt, Germany;

    Institute for Cardiovascular Regeneration, Centre of Molec- ular Medicine, Goethe-University Frankfurt, 60590 Frankfurt, Germany;

    Institute for Cardiovascular Regeneration, Centre of Molec- ular Medicine, Goethe-University Frankfurt, 60590 Frankfurt, Germany Division of Cardiology, Department of Medicine III, Goethe-University Frankfurt, 60590 Frankfurt, Germany;

    Institute for Cardiovascular Regeneration, Centre of Molec- ular Medicine, Goethe-University Frankfurt, 60590 Frankfurt, Germany Division of Cardiology, Department of Medicine III, Goethe-University Frankfurt, 60590 Frankfurt, Germany;

    Leibniz AG, Institute for Cardiovascular Regeneration, Goethe-University Frankfurt, 60590 Frankfurt, Germany;

    Institute for Cardiovascular Regeneration, Centre of Molec- ular Medicine, Goethe-University Frankfurt, 60590 Frankfurt, Germany;

    Division of Cardiology, Department of Medicine III, Goethe-University Frankfurt, 60590 Frankfurt, Germany;

    Institute for Cardiovascular Regeneration, Centre of Molec- ular Medicine, Goethe-University Frankfurt, 60590 Frankfurt, Germany;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 02:55:07

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号